Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Open Label, Non-Randomized, Study of Optimal Preoperative Therapy for Intrahepatic Cholangiocarcinoma (OPTIC)

NCT07639528 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT07639528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07639528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Open Label, Non-Randomized, Study of Optimal Preoperative Therapy for Intrahepatic Cholangiocarcinoma (OPTIC)
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
December 10, 2027
Completion date
December 10, 2031
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

resectable intrahepatic cholangiocarcinoma